- Moderated poster presentation
- Open Access
Assessment of left atrial and left atrial appendage flow and stasis in atrial fibrillation
© Markl et al; licensee BioMed Central Ltd. 2015
- Published: 3 February 2015
- Atrial Fibrillation
- Left Atrial
- Atrial Fibrillation Patient
- Persistent Atrial Fibrillation
- Left Atrial Appendage
Atrial fibrillation (AF) is associated with increased risk of stroke due to development of left atrial (LA) thrombus . Thromboembolic risk is assessed by clinical risk scores (CHA2DS2-VASc). However, these scores have limited predictive value. Echocardiography studies have shown that physiologic factors such as decreased atrial blood flow and increased stasis (LA velocities <0.2m/s) are associated with thrombus formation in the left atrial appendage (LAA) and may thus be better predictors for stroke . Currently available diagnostic tools such as transesophageal echocardiography (TEE), however, are limited as they do not completely assess the complex 3D LA blood flow and are invasive. We have recently shown that atrial 4D flow MRI can overcome these limitations and detect physiologic changes in LA flow in patients with AF, i.e. potentially different predisposition to atrial thrombogenesis. However, previous studies were limited by the lack of a systematic evaluation of differences in LA vs. LAA (site of thrombus formation) and intuitive visualization and quantification of LA and LAA stasis .
For an AF patient with CHA2DS2-VASc=1, Fig. 1A illustrates the strategy for assessing global and regional LA and LAA velocity and stasis (Fig.1B). In this seemingly low risk AF patient, flow quantification demonstrated considerably altered velocities and stasis in the LAA, the primary site of atrial thrombogenesis, compared to the LA. AF patients showed highly individualized differences between LA and LAA hemodynamics (Fig. 1C,D). Noticeably, AF patients in sinus rhythm at low CHA2DS2-VASc score (median=1) demonstrated increased LA vs. LAA variability (14±13% LA vs. LAA difference) compared to patients in persistent AF at higher risk (median CHA2DS2-VASc=4, 9±8% LA vs. LAA difference).
Flow velocity and stasis measured in the LAA appear to be independent from the same measures in the LA. Thus, regional flow differences may be an important consideration for the assessment of thrombotic risk in patients with AF. In addition, our findings suggest that a seemingly low risk score, as defined by current clinical risk scores, may mask potentially relevant physiologic measures, such as elevated stasis in the LAA, the primary site of thrombogenesis.
AHA (12GRNT12080032) and NIH-NHLBI (1R21HL113895).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.